Ironwood Pharmaceuticals Inc IRWD:NASDAQ

Last Price$10.72Cboe Previous Close - Real-Time Last Sale as of 4:00PM ET 7/19/19
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$10.61 (700)
Ask (Size)$10.73 (200)
Day Low / HighN/A - N/A
Volume967.4 K
 

View Pharmaceuticals: Other IndustryPeer Comparison as of 07/19/2019

 

Ironwood Pharmaceuticals Inc ( NASDAQ )

Price: $10.72
Change: 0.00 (0.00%)
Volume: 967.4 K
4:00PM ET 7/19/2019
 
 

Supernus Pharmaceuticals Inc ( NASDAQ )

Price: $32.03
Change: +0.01 (0.03%)
Volume: 311.7 K
3:59PM ET 7/19/2019
 
 

Pacira Biosciences Inc ( NASDAQ )

Price: $39.87
Change: -0.01 (0.03%)
Volume: 340.3 K
3:59PM ET 7/19/2019
 
 

Prestige Consumer Healthcare Inc ( NYSE )

Price: $32.09
Change: 0.00 (0.00%)
Volume: 265.3 K
4:00PM ET 7/19/2019
 
 

Portola Pharmaceuticals Inc ( NASDAQ )

Price: $26.64
Change: -0.24 (0.89%)
Volume: 750.4 K
4:00PM ET 7/19/2019
 

Read more news Recent News

Analyst Actions: Credit Suisse Starts Ironwood Pharmaceuticals at Neutral
11:54AM ET 7/10/2019 MT Newswires

Ironwood Pharmaceuticals' (IRWD) average rating among analysts is a hold, with an average price target of $15. Price: 10.39, Change: +0.03, Percent Change:...

After Hours Watch List Scorecard: IRWD, QUIK, SESN
5:14PM ET 6/19/2019 MT Newswires

Here's how the stocks on Tuesday's After Hours Watch List performed during today's regular session AFTER HOURS REGULAR SESSION IRWD ...

Sector Update: Health Care Stocks Lead Markets to Modest Rise
3:52PM ET 6/19/2019 MT Newswires

Top Health Care Stocks JNJ +0.09% PFE +0.19% ABT +0.31% MRK +0.17% AMGN +0.07% Health care stocks extended their prior gains, including a nearly 1.0%...

Sector Update: Health Care Stocks Rising in Defensive Session
1:36PM ET 6/19/2019 MT Newswires

Top Health Care Stocks JNJ +0.09% PFE +0.19% ABT +0.31% MRK +0.17% AMGN +0.07% Health care stocks were moderately higher this afternoon, including a...

Company Profile

Business DescriptionIronwood Pharmaceuticals, Inc. is a commercial biotechnology company, which engages in the discovery, commercialization, and development of medicines. Its products include linaclotide, a guanylate cyclase type-C agonist which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller in 1998 and is headquartered in Cambridge, MA. View company web site for more details
Address301 Binney Street
Cambridge, Massachusetts 02142
Phone+1.617.621.7722
Number of Employees515
Recent SEC Filing07/11/20193
Chief Executive Officer & DirectorMark Mallon
PresidentThomas A. McCourt
Chief Financial Officer & Senior Vice PresidentGina R. Consylman
Chief Medical Officer & Senior Vice PresidentMichael Shetzline

Company Highlights

Price Open$10.64
Previous Close$10.72
52 Week Range$9.07 - 20.33
Market Capitalization$1.7 B
Shares Outstanding155.6 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement08/05/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.29
Beta vs. S&P 500N/A
Revenue$346.6 M
Net Profit Margin-86.22%
Return on Equity176.95%

Analyst Ratings as of 07/12/2019

Buy
4
Overweight
0
Hold
6
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset